CollPlant Biotechnologies announced in July 2024 the release of its inaugural Environmental, Social and Corporate Governance (ESG) and Sustainability Report, covering the year 2023. This report details the initiatives the company has undertaken to adopt a comprehensive ESG strategy.
The report focuses on pillars representing areas of highest impact, including enhancing plant-based production, reducing emissions, and delivering safe and reliable medical solutions. This aligns the company's operations with its ethical commitments.
The publication reflects CollPlant's commitment to fostering environmental sustainability, advancing social and corporate governance objectives, and enhancing human health. This strategic move aims to contribute to the company's overall impact and long-term value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.